Journal Information
Vol. 47. Issue 5.
Pages 226-233 (January 2011)
Share
Share
Download PDF
More article options
Vol. 47. Issue 5.
Pages 226-233 (January 2011)
Original Article
Full text access
Variability in the Performing of Spirometry and Its Consequences in the Treatment of COPD in Primary Care
Variabilidad en la realización de la espirometría y sus consecuencias en el tratamiento de la EPOC en Atención Primaria
Visits
4580
Mònica Monteagudoa,b,
Corresponding author
mmonteagudo@idiapjgol.org

Corresponding author.
, Teresa Rodriguez-Blancoa, Judith Parcetc, Núria Peñalverd, Carles Rubioe, Montserrat Ferrerf,g, Marc Miravitllesh
a Área científica IDIAP Jordi Gol, Barcelona, Spain
b Programa de doctorado en Salud Pública, Universitat Autònoma de Barcelona, Spain
c ABS Sant Ildefons, SAP Baix Llobregat Centre, Institut Català de la Salut, Cornellà de Llobregat, Barcelona, Spain
d ABS Martí Julià, SAP Baix Llobregat Centre, Institut Català de la Salut, Cornellà de Llobregat, Barcelona, Spain
e ABS Florida Nord, SAP Baix Llobregat Centre, Institut Català de la Salut, Hospitalet de Llobregat, Barcelona, Spain
f Unidad de Investigación en Servicios Sanitarios, IMIM-Hospital del Mar, Barcelona, Parc de Recerca Biomèdica de Barcelona, Spain
g School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
h Fundació Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain
This item has received
Article information
Abstract
Background

Several studies have dealt with the use of spirometry in the treatment of chronic obstructive pulmonary disease (COPD) in Primary Care (PC), but few have analyzed its impact on the treatment of the patient with COPD.

Objectives

To evaluate the use of spirometry in the diagnosis and follow-up of COPD patients in PC, and its impact on treatment. To analyze the variation in the performing of spirometry between PC centers.

Methodology

A multicenter, observational and cross-sectional study of COPD patients seen in PC in Catalonia (Spain) during 2004–2005. A multilevel logistic regression model was used to identify factors associated with having spirometry and to determine the variation between the different centers.

Result

Twenty-one centers, including 801 patients, participated. Only 53.2% of them had diagnostic spirometry and the mean (standard deviation) FEV1(%) was 54.8% (18%). The registers of smoking habits, complementary tests and spirometry follow-up were more common among patients who had a diagnostic spirometry available compared with those who did not. No statistically significant differences were found regarding demographic, clinical, treatment and quality of life variables between patients with and without follow-up spirometry. Significant variation was observed in the percentage of diagnostic spirometries between different PC centers (variance=0.217; p<0.001).

Conclusion

Spirometry is underused in PC and performing it during follow-up is not associated with the different treatments guidelines or with a more complete approach to the disease. There is significant variation in the performing of spirometry among PC centers.

Keywords:
Chronic obstructive pulmonary disease
Spirometry
Primary Care
Treatment
Resumen
Antecedentes

Algunos estudios han abordado el uso de la espirometría en la enfermedad pulmonar obstructiva crónica (EPOC) en Atención Primaria (AP), y pocos han analizado su impacto en el tratamiento del paciente con EPOC.

Objetivos

Valorar la utilización de la espirometría en el diagnóstico y seguimiento de los pacientes EPOC en AP y su impacto en el tratamiento. Analizar la variabilidad en la realización de espirometrías entre los centros de AP.

Metodología

Estudio multicéntrico, observacional y transversal en pacientes EPOC atendidos en AP de Catalunya (España) durante 2004–2005. Se usó un modelo de regresión logística multinivel para identificar factores asociados con tener espirometría y determinar la variabilidad entre los diferentes centros.

Resultados

Participaron 21 centros, que incluyeron 801 pacientes. Solo el 53,2% disponían de espirometría diagnóstica, la media (desviación estándar) del FEV1(%) fue 54,8% (18%). Los registros del hábito tabáquico, pruebas complementarias y espirometrías de seguimiento estuvieron más presentes entre los pacientes que disponían de espirometría diagnóstica respecto a aquellos que no la disponían. No se encontraron diferencias estadísticamente significativas respecto a variables demográficas, clínicas, tratamiento y calidad de vida entre pacientes con o sin espirometría de seguimiento. Se observó variabilidad significativa en el porcentaje de espirometrías diagnósticas entre los diferentes centros de AP (varianza=0,217; p<0,001).

Conclusión

La espirometría en AP está infrautilizada y su realización durante el seguimiento no se asocia a unas pautas distintas de tratamiento ni a un abordaje más completo de la enfermedad. Existe variabilidad significativa en la realización de espirometrías entre los centros de AP

Palabras clave:
Enfermedad pulmonar obstructiva crónica
Espirometría
Atención Primaria
Tratamiento
Full text is only aviable in PDF
References
[1.]
S. Hurd.
The impact of COPD on lung health worldwide: epidemiology and incidence.
Chest, 117 (2000), pp. S1-S4
[2.]
M. Miravitlles, J.B. Soriano, F. García-Río, L. Muñoz, E. Duran-Tauleria, G. Sanchez, et al.
Prevalence of COPD in Spa impact of undiagnosed COPD on quality of life daily life activities.
Thorax, 64 (2009), pp. 863-868
[3.]
V.S. Peña, M. Miravitlles, R. Gabriel, C.A. Jiménez-Ruíz, C. Villasante, J.F. Masa, et al.
Geographic variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC multicentre epidemiological study.
Chest, 118 (2000), pp. 981-989
[4.]
M. Miravitlles, C. de la Roza, J. Morera, T. Montemayor, E. Gobartt, A. Martín, et al.
Chronic respiratory symptoms, spirometry and knowledge of COPD among general population.
Respir Med, 100 (2006), pp. 1973-1980
[5.]
J. Clotet, X. Gómez-Arbonés, C. Ciria, J.M. Albalad.
Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care.
Arch Bronconeumol, 40 (2004), pp. 155-159
[6.]
D.A. Kaminsky, T.W. Marcy, M. Bachand, C.G. Irvin.
Knowledge and use of Office Spirometry for the detection of chronic obstructive pulmonary disease by primary care physicians.
Respir Care, 50 (2005), pp. 1639-1648
[7]
K. Naberan, C. de la Roza, M. Lamban, E. Gobartt, A. Martín, M. Miravitlles.
Use of spirometry in the diagnosis and treatment of chronic obstructive pulmonary disease in primary care.
Arch Bronconeumol, 42 (2006), pp. 638-644
[8.]
T.A. Lee, B. Bartle, K.B. Weiss.
Spirometry use in clinical practice following diagnosis of COPD.
Chest, 129 (2006), pp. 1509-1515
[9.]
P.P. Walker, P. Mitchell, F. Diamantea, C.J. Warburton, L. Davies.
Effect of primary-care spirometry on the diagnosis anagement of COPD.
Eur Respir J, 28 (2006), pp. 945-952
[10.]
R.E. Dales, K.L. Vandemheen, J. Clinch, S.D. Aaron.
Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction.
Chest, 128 (2005), pp. 2443-2447
[11.]
M. Miravitlles, C. Murio, T. Guerrero, J.L. Segú.
Treatment of chronic bronchitis and chronic pulmonary obstructive disease in primary care.
Arch Bronconeumol, 35 (1999), pp. 173-178
[12.]
C. Valero, M. Monteagudo, M. Llagostera, X. Bayona, S. Granollers, M. Acedo, et al.
Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): Information and health education feedback for improving clinical monitoring and quality-of-life.
BMC Public Health, 9 (2009), pp. 442
[13.]
P.W. Jones, F.H. Quirk, C.M. Baveytock, P. LittleJohns.
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.
Am Rev Respir Dis, 145 (1992), pp. 1321-1327
[14.]
P.W. Jones.
Interpreting thresholds for clinically significant change in health status in asthma and COPD.
Eur Respir J, 19 (2002), pp. 398-404
[15.]
M. Ferrer, J. Alonso, L. Prieto, V. Plaza, E. Monsó, R. Marrades, et al.
Validity reliability of the St. George's Respiratory Questionnaire after adaption to a different language culture the Spanish example.
Eur Respir J, 9 (1996), pp. 1160-1166
[16.]
J.C. Bestall, E.A. Paul, R. Garrod, R. Garnham, P.W. Jones, J.A. Wedzicha.
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.
Thorax, 54 (1999), pp. 581-586
[17.]
J. Giner, L.V. Basualdo, P. Casan, C. Hernández, V. Macián, I. Martínez, et al.
Guideline for the use of inhaled drugs The working group of SEPAR: the Nursing Area of the Sociedad Española de Neumología y Cirugía Torácica.
Arch Bronconeumol, 36 (2000), pp. 34-43
[18.]
S.W. Raudenbush, A.S. Bryk.
Assessing the Adequacy of Hierarchical Models.
Hierarchical Linear Models. Applications and Data Analysis Methods, pp. 252-286
[19.]
H. Goldstein.
Bedford Group for Lifecourse and Statistical Studies.
Multilevel statistical models, 3rd ed, Arnold, (2003),
[20.]
T. Snijders, R. Bosker.
Multilevel analysis. An introduction to basic and advanced multilevel modeling.
Sage Publications, (1999),
[21.]
H. Goldstein, W. Browne, J. Rasbash.
Partitioning Variation in Multilevel Models.
Understanding Statistics, 1 (2008), pp. 223-231
[22.]
D.W. Hosmer, S.A. Lemeshow.
Assessing the Fit of the Model.
Applied Logistic Regression, 2nd ed, pp. 143-202
[23.]
E. Derom, C. Van Weel, G. Liistro, J. Buffels, T. Schermer, E. Lammers, et al.
Primary care spirometry.
Eur Respir J, 31 (2008), pp. 197-203
[24.]
K. Naberan.
Encuesta de la actitud terapéutica de control de los médicos generales de las ABS de Barcelona, respecto a enfermedades obstructivas respiratorias.
Aten Primaria, 13 (1994), pp. 112-116
[25.]
J. De Miguel Díez, J.L. Izquierdo Alonso, J. Molina París, J.M. Rodríguez González-Moro, P. de Lucas Ramos, G. Gaspar Alonso-Vega.
Fiabilidad del diagnóstico de la EPOC en atención primaria y neumología en España Factores predictivos.
Arch Bronconeumol, 39 (2003), pp. 203-208
[26.]
M. Miravitlles, C. De la Roza, K. Naberan, M. Lamban, E. Gobartt, A. Martín.
Use of spirometry and patterns of prescribing in COPD in primary care.
Respir Med, 101 (2007), pp. 1753-1760
[27.]
J. Buffels, J. Degryse, J. Heyrman, M. Decramer.
Office spirometry significantly improves early detection of COPD in general practice. DIDASCO study.
Chest, 125 (2004), pp. 1394-1399
[28.]
Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2006. Update on Dec, 2009. Available from: www.goldcopd.org.
[29.]
J.B. Soriano, M. Miravitlles, L. Borderías, E. Duran-Tauleria, F. García, J. Martínez, et al.
Diferencias geográficas en la prevalencia de EPOC en España: relación con hábito tabáquico, tasas de mortalidad y otros determinantes.
Arch Bronconeumol, 46 (2010), pp. 522-530
[30.]
J. García-Aymerich, F.P. Gómez, J.M. Antó.
En nombre del grupo Investigador del Estudio PAC-COPD. diseño y metodología.
Arch Bronconeumol, 45 (2009), pp. 4-11
[31.]
J. Ancochea, C. Badiola, E. Duran-Tauleria, F. Garcia Rio, M. Miravitlles, L. Muñoz, et al.
Estudio EPI-SCAN: resumen del protocolo de un estudio para estimar la prevalencia de EPOC en personas de 40 a 80 años en España.
Arch Bronconeumol, 45 (2009), pp. 41-47
[32.]
J.J. Soler-Cataluña, M. Calle, B.G. Cosío, J.M. Marín, E. Monsó, I. Alfageme.
Comité de Calidad Asistencial de la SEPAR; Área de Trabajo EPOC de la SEPAR. Estándares de calidad asistencial en la EPOC.
Arch Bronconeumol, 45 (2009), pp. 196-203
Copyright © 2011. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?